Another study revealed that CAF derived exosomes expressing CD9 and CD63 significantly diminished proliferative capacity of myeloma cell lines and lead to improved 5-year disease-free survival in patients bearing CAF derived CD9 positive exosomes compared to CAF derived CD9 negative patients [97]. Here, CD9 is linked to plasma cell myeloma.